Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Patompong Ungprasert, Narat Srivali & Charat Thongprayoon. (2016) Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis. Journal of Dermatological Treatment 27:4, pages 316-321.
Read now
Read now
Nawaf Al-Mutairi & Tarek Nour. (2014) The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Expert Opinion on Biological Therapy 14:6, pages 749-756.
Read now
Read now
Sarah E Churton, Kristen Doud & Neil J Korman. (2013) Comorbidities of psoriasis. Expert Review of Dermatology 8:3, pages 277-290.
Read now
Read now
Gleison Duarte, Luan Oliveira Barbosa & Maria Elisa A Rosa. (2012) The management of psoriasis through diet. Psoriasis: Targets and Therapy 2, pages 45-53.
Read now
Read now
Marina Papoutsaki, Antonio Costanzo & Sergio Chimenti. (2009) Emerging treatments in the management of psoriasis: biological targeting with ustekinumab. Clinical, Cosmetic and Investigational Dermatology 2, pages 95-103.
Read now
Read now
Jacob Dreiher & Arnon Cohen. (2009) More than skin deep: dyslipidemia in skin diseases. Clinical Lipidology 4:5, pages 533-536.
Read now
Read now
F. Prignano, F. Ricceri, L. Pescitelli, G. Buggiani, M. Troiano, F. Zanieri, S. Rossari & T. Lotti. (2009) Comparison of body weight and clinical-parameter changes following the treatment of plaque psoriasis with biological therapies. Current Medical Research and Opinion 25:9, pages 2311-2316.
Read now
Read now
Eric Q. Wu, Steve R. Feldman, Lei Chen, Anna Kaltenboeck, Andrew P. Yu, Shiraz R. Gupta, David Laitinen & Mary K. Willian. (2008) Utilization pattern of etanercept and its cost implications in moderate to severe psoriasis in a managed care population. Current Medical Research and Opinion 24:12, pages 3493-3501.
Read now
Read now
Marina Papoutsaki, Antonio Costanzo, Maria-Sole Chimenti & Sergio Chimenti. (2008) Adalimumab for the treatment of severe psoriasis and psoriatic arthritis. Expert Opinion on Biological Therapy 8:3, pages 363-370.
Read now
Read now
Alice B. Gottlieb, Chun Chao & Frank Dann. (2008) Psoriasis comorbidities. Journal of Dermatological Treatment 19:1, pages 5-21.
Read now
Read now
Paolo Gisondi, Francesca Fantuzzi, Mario Malerba & Giampiero Girolomoni. (2007) Folic acid in general medicine and dermatology. Journal of Dermatological Treatment 18:3, pages 138-146.
Read now
Read now
Gino A Vena & Nicoletta Cassano. (2006) Emerging drugs for psoriasis. Expert Opinion on Emerging Drugs 11:4, pages 567-596.
Read now
Read now
Articles from other publishers (75)
Chenyang Yu, Yingzhao Huang, Wei Yan & Xian Jiang. (2023) A comprehensive overview of psoriatic research over the past 20 years: machine learning-based bibliometric analysis. Frontiers in Immunology 14.
Crossref
Crossref
George Makavos, Ignatios Ikonomidis, Vaia Lambadiari, Georgia-Angeliki Koliou, George Pavlidis, John Thymis, Pinelopi Rafouli-Stergiou, Gavriella Kostelli, Konstantinos Katogiannis, Konstantinos Stamoulis, Aikaterini Kountouri, Emmanouil Korakas, Kostas Theodoropoulos, Alexandra Frogoudaki, Pelagia Katsimbri & Evangelia Papadavid. (2023) Additive prognostic value of longitudinal myocardial deformation to SCORE2 in psoriasis. European Heart Journal Open 3:2.
Crossref
Crossref
Lisa Schielke, Nick Zimmermann, Sarah Hobelsberger, Julian Steininger, Anne Strunk, Kristin Blau, Jessica Hernandez, Stephan Künzel, Robert Ziegenbalg, Sarah Rösing, Stefan Beissert, Susanne Abraham & Claudia Günther. (2022) Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells. Frontiers in Immunology 13.
Crossref
Crossref
Hansjörg Baurecht, Dennis Freuer, Christine Welker, Lam C. Tsoi, James T. Elder, Benjamin Ehmke, Michael F. Leitzmann, Birte Holtfreter & Sebastian‐Edgar Baumeister. (2022) Relationship between periodontitis and psoriasis: A two‐sample Mendelian randomization study. Journal of Clinical Periodontology.
Crossref
Crossref
Abbas Alshami, Nasam Alfraji, Steven Douedi, Swapnil Patel, Mohammad Hossain, Deborah Alpert & Dawn Calderon. (2021) Psoriasis as risk factor for non-ischemic dilated cardiomyopathy: a population-based cross-sectional study. BMC Cardiovascular Disorders 21:1.
Crossref
Crossref
Shang-Feng Yang, Ting-Hao Chen, Shin-Hung Tsai, Pei-En Chen, Ching-Chi Chi & Tao-Hsin Tung. (2021) Risk of chronic kidney disease and end-stage renal disease in patients with psoriasis: A systematic review and meta-analysis of cohort studies. Dermatologica Sinica 39:1, pages 19.
Crossref
Crossref
Sinan Özçelik, Fatma Arzu Kılıç & Rana Başara. (2020)
Retrospective analysis of patients with psoriasis receiving biological therapy:
Real‐life
data
. Dermatologic Therapy 33:6.
Crossref
Crossref
Eingun James Song. (2020) Tildrakizumab Shows Significant Efficacy in Psoriasis Treatment With Comorbid Immunoglobulin A Nephropathy: A Case Report. Journal of Psoriasis and Psoriatic Arthritis 5:4, pages 160-163.
Crossref
Crossref
Rosemary A. deShazo, Aaron M. Secrest, April W. Armstrong & Kristina Callis Duffin. (2020) Addressing Hypertension in Patients With Psoriasis: Review and Recommendations. Journal of Psoriasis and Psoriatic Arthritis 5:4, pages 129-138.
Crossref
Crossref
Artsiom Klimko, Georgiana A Toma, Laura Ion, Ana Maria Mehedinti & Iuliana Andreiana. (2020) A Case Report of Generalized Pustular Psoriasis Associated With IgA Nephropathy. Cureus.
Crossref
Crossref
Andrea Conti, Lisa Giovannini, Victor Desmond Mandel, Giulia Odorici, Claudia Lasagni, Laura Bigi, Giovanni Pellacani & Gianni Cappelli. (2020) Chronische Nierenerkrankung bei Psoriasis: eine Kohortenstudie. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18:5, pages 438-446.
Crossref
Crossref
Andrea Conti, Lisa Giovannini, Victor Desmond Mandel, Giulia Odorici, Claudia Lasagni, Laura Bigi, Giovanni Pellacani & Gianni Cappelli. (2020) Chronic kidney disease in psoriasis: a cohort study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18:5, pages 438-445.
Crossref
Crossref
Walter Masson, Martín Lobo & Graciela Molinero. (2020) Psoriasis and Cardiovascular Risk: A Comprehensive Review. Advances in Therapy 37:5, pages 2017-2033.
Crossref
Crossref
Marcelo Arnone, Maria Denise Fonseca Takahashi, André Vicente Esteves de Carvalho, Wanderley Marques Bernardo, Aline Lopes Bressan, Andrea Machado Coelho Ramos, Aripuanã Cobério Terena, Cacilda da Silva Souza, Daniel Holthausen Nunes, Maria Cecília de Carvalho Bortoletto, Maria de Fátima Santos Paim de Oliveira, Jane Marcy Neffá, Luciana Cristina Fieri, Luna Azulay-Abulafia, Paulo Antônio Oldani Felix, Renata Ferreira Magalhaes, Ricardo Romiti & Tatiana Jerez Jaime. (2019) Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia 94:2 suppl 1, pages 76-107.
Crossref
Crossref
Jung Eun Kim, Ho Jung Lee, Jong Suk Lee, Kyu Uang Whang, Young Lip Park, Sung Yul Lee & Hyun Jung Kim. (2019) Association between Homocysteine Levels and Psoriasis: A Meta-Analysis. Annals of Dermatology 31:4, pages 378.
Crossref
Crossref
Pierachille Santus, Maurizio Rizzi, Dejan Radovanovic, Andrea Airoldi, Andrea Cristiano, Rosalynn Conic, Stephen Petrou, Paolo Daniele Maria Pigatto, Nicola Bragazzi, Delia Colombo, Mohamad Goldust & Giovanni Damiani. (2018) Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Esra Adışen, Selda Uzun, Funda Erduran & Mehmet Ali Gürer. (2018) Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis. Anais Brasileiros de Dermatologia 93:2, pages 205-211.
Crossref
Crossref
Zohreh Tehranchinia, Esmat Ghanei, Nahid Mohammadi, Masoud Partovi-Kia, Hoda Rahimi & Nikoo Mozafari. (2018) No Relation between Psoriasis and Renal Abnormalities: A Case-Control Study. The Scientific World Journal 2018, pages 1-5.
Crossref
Crossref
Vure Prasad & Sundeep Chaurasia. (2017) Performance evaluation of non-ionic surfactant based tazarotene encapsulated proniosomal gel for the treatment of psoriasis. Materials Science and Engineering: C 79, pages 168-176.
Crossref
Crossref
Marina Talamonti, Simone D’Adamio, Luca Bianchi & Marco Galluzzo. (2017) The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature. Molecular Diagnosis & Therapy 21:5, pages 467-480.
Crossref
Crossref
Abidullah Khan, Iqbal Haider, Maimoona Ayub & Mohammad Humayun. (2017) Psoriatic Arthritis Is an Indicator of Significant Renal Damage in Patients with Psoriasis: An Observational and Epidemiological Study. International Journal of Inflammation 2017, pages 1-6.
Crossref
Crossref
Suad AlFadhli, Alaa A.M. Al-Zufairi, Rasheeba Nizam, Huda A. AlSaffar & Nawaf Al-Mutairi. (2016) De-regulation of diabetic regulatory genes in psoriasis: Deciphering the unsolved riddle. Gene 593:1, pages 110-116.
Crossref
Crossref
Rahime Inci, Perihan Ozturk, Mehmet Fatih Inci, Mehmet Kamil Mulayim, Mine Mujde Ozdemir & Ali Zorlu. (2016) Carotid intima–media thickness, nonalcoholic fatty liver disease, and hemoglobin A1c are independently associated with the severity of psoriasis. Dermatologica Sinica 34:3, pages 135-140.
Crossref
Crossref
Justin Besen, Laura E. McDermott, Christina Lam, Aaron Legler, Katy Burris & Amit Garg. (2016) Validation and Comparison of Psoriasis Case-Finding Algorithms Using International Classification of Diseases Nosology. Journal of Psoriasis and Psoriatic Arthritis 1:3, pages 123-127.
Crossref
Crossref
Z.K. Jabbar-Lopez, S.C. Weatherhead & N.J. Reynolds. (2016) Kidney disease in moderate-to-severe psoriasis: a critical appraisal. British Journal of Dermatology 174:2, pages 267-270.
Crossref
Crossref
Yu. S. Kondratyeva, S. N. Shansin & A. A. Vedler. (2016) Evaluation of risk factors for cardiovascular diseases in patients with psoriasis. Klinicheskaya dermatologiya i venerologiya 15:4, pages 36.
Crossref
Crossref
Xin Li, Lingjun Kong, Fulun Li, Chen Chen, Rong Xu, Hongshen Wang, Shiguang Peng, Min Zhou & Bin Li. (2015) Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. PLOS ONE 10:12, pages e0145221.
Crossref
Crossref
Sylwia Milaniuk, Aldona Pietrzak, Barbara Mosiewicz, Jerzy Mosiewicz & Kristian Reich. (2015) Influence of psoriasis on circulatory system function assessed in echocardiography. Archives of Dermatological Research 307:10, pages 855-861.
Crossref
Crossref
Ching-Chi Chi, Jui Wang, Yu-Fen Chen, Shu-Hui Wang, Fu-Li Chen & Tao-Hsin Tung. (2015) Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: A nationwide population-based cohort study. Journal of Dermatological Science 78:3, pages 232-238.
Crossref
Crossref
Jacqueline Vanderpuye-Orgle, Yang Zhao, Jackie Lu, Anshu Shrestha, Alison Sexton, Seth Seabury & Mark Lebwohl. (2015) Evaluating the economic burden of psoriasis in the United States. Journal of the American Academy of Dermatology 72:6, pages 961-967.e5.
Crossref
Crossref
Matthias Augustin, Marc A. Radtke, Gerd Glaeske, Kristian Reich, Enno Christophers, Ines Schaefer & Arnd Jacobi. (2015) Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema. Dermatology 231:1, pages 35-40.
Crossref
Crossref
Marisa Kardos Garshick & Alexa Boer Kimball. (2015) Psoriasis and the Life Cycle of Persistent Life Effects. Dermatologic Clinics 33:1, pages 25-39.
Crossref
Crossref
H.S. Park, S.J. Koh, G.Y. Park, D.H. Lee, H.S. Yoon, J.I. Youn & S. Cho. (2013) Psoriasis concurrent with inflammatory bowel disease. Journal of the European Academy of Dermatology and Venereology 28:11, pages 1436-1441.
Crossref
Crossref
C. De Simone, G. Caldarola, V. Coco, S. Palumbo, K. Pocino, A. Sgambato, A. Maiorino, M. Corbi, M.T. Sandri, F. Vendittelli & E. Capoluongo. (2014) Circulating endothelial cell levels in psoriatic patients and their modification after an anti-TNF-alpha (Etanercept) treatment. Journal of the European Academy of Dermatology and Venereology 28:5, pages 590-596.
Crossref
Crossref
Ivan Grozdev, Neil Korman & Nikolai Tsankov. (2014) Psoriasis as a systemic disease. Clinics in Dermatology 32:3, pages 343-350.
Crossref
Crossref
E. Daudén, S. Castañeda, C. Suárez, J. García-Campayo, A.J. Blasco, M.D. Aguilar, C. Ferrándiz, L. Puig & J.L. Sánchez-Carazo. (2013) Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology 27:11, pages 1387-1404.
Crossref
Crossref
Maddalena Gaeta, Serenella Castelvecchio, Cristian Ricci, Paolo Pigatto, Gabriele Pellissero & Riccardo Cappato. (2013) Role of psoriasis as independent predictor of cardiovascular disease: A meta-regression analysis. International Journal of Cardiology 168:3, pages 2282-2288.
Crossref
Crossref
Jacob Dreiher, Tamar Freud & Arnon D. Cohen. (2013) Psoriatic Arthritis and Diabetes: A Population-Based Cross-Sectional Study. Dermatology Research and Practice 2013, pages 1-7.
Crossref
Crossref
M.A. González-Gay, C. González-Vela & C. González-Juanatey. (2012) Psoriasis: a Skin Disease Associated With Increased Cardiovascular Risk. Actas Dermo-Sifiliográficas (English Edition) 103:7, pages 595-598.
Crossref
Crossref
M.A. González-Gay, C. González-Vela & C. González-Juanatey. (2012) Psoriasis: una enfermedad cutánea relacionada con riesgo cardiovascular elevado. Actas Dermo-Sifiliográficas 103:7, pages 595-598.
Crossref
Crossref
J. Ahdout, J. Kotlerman, D. Elashoff, J. Kim & M. W. Chiu. (2012) Modifiable lifestyle factors associated with metabolic syndrome in patients with psoriasis. Clinical and Experimental Dermatology 37:5, pages 477-483.
Crossref
Crossref
S. Armesto, P. Coto-Segura, C.G. Osuna, P.M. Camblor & J. Santos-Juanes. (2012) Psoriasis and hypertension: a case-control study. Journal of the European Academy of Dermatology and Venereology 26:6, pages 785-788.
Crossref
Crossref
A.M. Binus, J. Han, A.A. Qamar, E.A. Mody, E.W. Holt & A.A. Qureshi. (2012) Associated comorbidities in psoriasis and inflammatory bowel disease. Journal of the European Academy of Dermatology and Venereology 26:5, pages 644-650.
Crossref
Crossref
Wenqing Li, Jiali Han, Frank B. Hu, Gary C. Curhan & Abrar A. Qureshi. (2012) Psoriasis and Risk of Type 2 Diabetes among Women and Men in the United States: A Population-Based Cohort Study. Journal of Investigative Dermatology 132:2, pages 291-298.
Crossref
Crossref
Jonathan Shapiro, Arnon David Cohen, Dahlia Weitzman, Roy Tal & Michael David. (2012) Psoriasis and cardiovascular risk factors: A?case-control study on inpatients comparing psoriasis to dermatitis. Journal of the American Academy of Dermatology 66:2, pages 252-258.
Crossref
Crossref
Y.-Y. Chiang & H.-W. Lin. (2012) Association between psoriasis and chronic obstructive pulmonary disease: a population-based study in Taiwan. Journal of the European Academy of Dermatology and Venereology 26:1, pages 59-65.
Crossref
Crossref
E. Daudén, S. Castañeda, C. Suárez, J. García-Campayo, A.J. Blasco, M.D. Aguilar, C. Ferrándiz, L. Puig & J.L. Sánchez-Carazo. (2012) Integrated Approach to Comorbidity in Patients With Psoriasis. Actas Dermo-Sifiliográficas (English Edition) 103, pages 1-64.
Crossref
Crossref
E. Daudén, S. Castañeda, C. Suárez, J. García-Campayo, A.J. Blasco, M.D. Aguilar, C. Ferrándiz, L. Puig & J.L. Sánchez-Carazo. (2012) Abordaje integral de la comorbilidad del paciente con psoriasis. Actas Dermo-Sifiliográficas 103, pages 1-64.
Crossref
Crossref
A.-M. Tobin, R. Hughes, E. B. Hand, T. Leong, I. M. Graham & B. Kirby. (2011) Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case–control study. Clinical and Experimental Dermatology 36:1, pages 19-23.
Crossref
Crossref
Nora Kogan, Rosana Veira, Elena Chaparro, Alejandra Crespo, Simón Gusis & Mercedes Hassan. (2018) Comorbidities in Psoriasis. Psoriasis Forum 16a:3, pages 23-30.
Crossref
Crossref
Ayse Serap Karadag, Bunyamin Yavuz, Derun Taner Ertugrul, Kadir Okhan Akin, Ahmet Arif Yalcin, Onur Sinan Deveci, Naim Ata, Metin Kucukazman & Kursad Dal. (2010) Is psoriasis a pre-atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis. International Journal of Dermatology 49:6, pages 642-646.
Crossref
Crossref
F Prignano, L Pescitelli, F Ricceri & T Lotti. (2010) Retrospective analysis of systemic treatments for psoriasis patients attending a Psocare center in Florence. Relevance of biological drugs use and comorbidities. Journal of the European Academy of Dermatology and Venereology 24:5, pages 555-560.
Crossref
Crossref
E Christophers, JNWN Barker, CEM Griffiths, E Daudén, G Milligan, C Molta, R Sato & R Boggs. (2010) The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. Journal of the European Academy of Dermatology and Venereology 24:5, pages 548-554.
Crossref
Crossref
Alexa Boer Kimball, Annie Guerin, Dominick Latremouille-Viau, Andrew P. Yu, Shiraz Gupta, Yanjun Bao & Parvez Mulani. (2010) Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective Analysis. The American Journal of Medicine 123:4, pages 350-357.
Crossref
Crossref
Jana Hercogová, Frederica Ricceri, Lara Tripo, Torello Lotti & Francesca Prignano. (2010) Psoriasis and body mass index. Dermatologic Therapy 23:2, pages 152-154.
Crossref
Crossref
M. Augustin, G. Glaeske, M.A. Radtke, E. Christophers, K. Reich & I. Schäfer. (2010) Epidemiology and comorbidity of psoriasis in children. British Journal of Dermatology 162:3, pages 633-636.
Crossref
Crossref
Nawaf AL‐MUTAIRI, Shahat AL‐FARAG, Ahmed AL‐MUTAIRI & Mazen AL‐SHILTAWY. (2010) Comorbidities associated with psoriasis: An experience from the Middle East. The Journal of Dermatology 37:2, pages 146-155.
Crossref
Crossref
Alice B. Gottlieb & Frank Dann. (2009) Comorbidities in Patients with Psoriasis. The American Journal of Medicine 122:12, pages 1150.e1-1150.e9.
Crossref
Crossref
Alexa Boer Kimball & Ying Wu. (2009) Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. International Journal of Dermatology 48:11, pages 1147-1156.
Crossref
Crossref
Yaowei Zhu, Chuanpu Hu, Ming Lu, Sam Liao, Joseph C. Marini, Jennifer Yohrling, Newman Yeilding, Hugh M. Davis & Honghui Zhou. (2009) Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL-12/23p40, in Patients With Moderate to Severe Plaque Psoriasis. The Journal of Clinical Pharmacology 49:2, pages 162-175.
Crossref
Crossref
Y.B. Brauchli, S.S. Jick & C.R. Meier. (2008) Psoriasis and the risk of incident diabetes mellitus: a population-based study. British Journal of Dermatology 159:6, pages 1331-1337.
Crossref
Crossref
Joseph F. Fowler, Mei Sheng Duh, Ludmila Rovba, Sharon Buteau, Lisa Pinheiro, Francis Lobo, Jennifer Sung, Joseph J. Doyle, Andrine Swensen, David A. Mallett & George Kosicki. (2008) The impact of psoriasis on health care costs and patient work loss. Journal of the American Academy of Dermatology 59:5, pages 772-780.
Crossref
Crossref
J. Dreiher, D. Weitzman, J. Shapiro, B. Davidovici & A.D. Cohen. (2008) Psoriasis and chronic obstructive pulmonary disease: a case-control study. British Journal of Dermatology 159:4, pages 956-960.
Crossref
Crossref
F. Späh. (2008) Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. British Journal of Dermatology 159, pages 10-17.
Crossref
Crossref
S. Gerdes, V.A. Zahl, H. Knopf, M. Weichenthal & U. Mrowietz. (2008) Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis. British Journal of Dermatology.
Crossref
Crossref
J.-P. Ortonne. (2008) Quels sont les objectifs du traitement du psoriasis modéré à sévère ?. Annales de Dermatologie et de Vénéréologie 135, pages S281-S284.
Crossref
Crossref
AD Cohen, J Dreiher, Y Shapiro, L Vidavsky, DA Vardy, B Davidovici & J Meyerovitch. (2008) Psoriasis and diabetes: a population-based cross-sectional study. Journal of the European Academy of Dermatology and Venereology 22:5, pages 585-589.
Crossref
Crossref
Michael L. Shelling, Daniel G. Federman, Srdjan Prodanovich & Robert S. Kirsner. (2008) Psoriasis and Vascular Disease: An Unsolved Mystery. The American Journal of Medicine 121:5, pages 360-365.
Crossref
Crossref
Yolanda B. Brauchli, Susan S. Jick, François Curtin & Christoph R. Meier. (2008) Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study. Journal of the American Academy of Dermatology 58:3, pages 421-429.
Crossref
Crossref
Ulrich Mrowietz, James T. Elder & Jonathan Barker. (2006) The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Archives of Dermatological Research 298:7, pages 309-319.
Crossref
Crossref
Enno Christophers. (2007) Comorbidities in psoriasis. Clinics in Dermatology 25:6, pages 529-534.
Crossref
Crossref
L. Puig-Sanz. (2007) La psoriasis, ¿una enfermedad sistémica?. Actas Dermo-Sifiliográficas 98:6, pages 396-402.
Crossref
Crossref
L. Puig Sanz. (2007) Psoriasis, a Systemic Disease?. Actas Dermo-Sifiliográficas (English Edition) 98:6, pages 396-402.
Crossref
Crossref
I Biyik, A Narin, MA Bozok & O Ergene. (2016) Echocardiographic and Clinical Abnormalities in Patients with Psoriasis. Journal of International Medical Research 34:6, pages 632-639.
Crossref
Crossref
E Christophers. (2006) Comorbidities in psoriasis. Journal of the European Academy of Dermatology and Venereology 20:s2, pages 52-55.
Crossref
Crossref